
Structure-guided design of a targeted autoantibody degrader for neurologic disease
Zimanyi, M., Dayao, M., Asencor, A.I., Kondapavulur, S., Asaki, J., McCutcheon, K., Dabaco, C., Bodansky, A., Craik, C.S., Pleasure, S.J., et al.


Autoimmune encephalitis (AE) is a rare condition where antibodies target brain antigens leading to severe cognitive dysfunction, but the identity of these antibodies is often unknown. We are developing functional genomic and computational tools to discover the source, target, and mechanism of new pathogenic autoantibodies.

Current treatments for autoimmune neurological diseases are nonspecific, ineffective, and/or neurotoxic. How can we eliminate pathogenic autoantibodies while leaving the rest of the immune system intact?


Zimanyi, M., Dayao, M., Asencor, A.I., Kondapavulur, S., Asaki, J., McCutcheon, K., Dabaco, C., Bodansky, A., Craik, C.S., Pleasure, S.J., et al.

Pluvinage, J.V., Acero-Garces, D., Greco, G., Moseley, C.E., Sidhu, S., Zorn, K.C., Kondapavulur, S., Richie, M., Douglas, V., Mohan, S., et al.

Pluvinage JV, Ngo T, Fouassier C, McDonagh M, Holmes BB, Bartley CM, Kondapavulur S, Hurabielle C, Bodansky A, Pai V, Hinman S, Aslanpour A, Alvarenga BD, Zorn KC, Zamecnik C, McCann A, Asencor AI, Huynh T, Browne W, Tubati A, Haney MS, Douglas VC, Louine M, Cree BAC, Hauser SL, Seeley W, Baranzini SE, Wells JA, Spudich S, Farhadian S, Ramachandran PS, Gillum L, Hales CM, Zikherman J, Anderson MS, Yazdany J, Smith B, Nath A, Suh G, Flanagan EP, Green AJ, Green R, Gelfand JM, DeRisi JL, Pleasure SJ, Wilson MR.

John V Pluvinage, Jerry Sun, Christel Claes, Ryan A Flynn, Michael S Haney, Tal Iram, Xiangling Meng, Rachel Lindemann, Nicholas M Riley, Emma Danhash, Jean Paul Chadarevian, Emma Tapp, David Gate, Sravani Kondapavulur, Inma Cobos, Sundari Chetty, Anca M Pașca, Sergiu P Pașca, Elizabeth Berry-Kravis, Carolyn R Bertozzi, Mathew Blurton-Jones, Tony Wyss-Coray

John V. Pluvinage, Michael S. Haney, Benjamin A. H. Smith, Jerry Sun, Tal Iram, Liana Bonanno, Lulin Li, Davis P. Lee, David W. Morgens, Andrew C. Yang, Steven R. Shuken, David Gate, Madeleine Scott, Purvesh Khatri, Jian Luo, Carolyn R. Bertozzi, Michael C. Bassik & Tony Wyss-Coray

John is an Assistant Professor of Neurology at the University of California, San Francisco. He received his BS in Bioengineering and then MD and PhD from Stanford, investigating mechanisms of microglial aging and rejuvenation. He completed his clinical Neurology residency and postdoctoral fellowship at UCSF focusing on the overlap between autoimmunity and neurodegeneration. His research has been recognized by a Burroughs Wellcome Fund Career Award for Medical Scientists, a NIH K08 Career Development Award, and the American Academy of Neurology’s S. Weir Mitchell Award.

Berkeley received his BA in human psychology from San Jose State University before completing his PhD on sleep electrophysiology from Stanfur. In his free time, he enjoys chasing squirrels and chewing on milk cartons.

Natalia is a Senior Scientist at the Arc Institute with expertise spanning structural biology, vaccine development, and cell therapy. She earned her PhD from UC Berkeley, where she studied protein structure and signaling using X-ray crystallography. As a scientist in the Kim Lab at Stanford, she contributed to vaccine development efforts targeting SARS-CoV-2 and HIV, before going on to lead the molecular assays group at Adicet Bio. In the Pluvinage Lab, she draws on this interdisciplinary background to develop molecular and biochemical tools that rigorously investigate the underexplored role of autoimmune mechanisms in neurological disease and brain aging. Outside the lab, she enjoys traveling, gardening, and hiking.

Bonny is a Staff Research Associate at the Arc Institute. She received her BA in Molecular and Cell Biology with a focus in Immunology and Pathogenesis from UC Berkeley. Previously, she conducted autoantibody discovery in the Wilson Lab at UCSF and contributed to early drug discovery efforts at Arcus Biosciences. In the Pluvinage Lab, Bonny will be focusing on further autoantibody discovery efforts related to neurodegeneration. She enjoys crocheting and hiking national parks in her free time.

Richard is a 1st year Biology PhD student from Stanford. He received his BS in Life Sciences from Ateneo de Manila University (Philippines). He completed his MSc in Molecular Mechanisms at Radboud University (Netherlands), including an internship at Boston Children's Hospital where he developed VHH tools to dissect the basic mechanisms of E2 ubiquitin-conjugating enzymes. Before starting graduate school, he worked at Cradle, a techbio start-up based in the Netherlands, to build high-throughput workflows to characterize and optimize antibody fragments. Outside of work, he enjoys painting, hiking, and reading.
